However, p62 might act as a tumor suppressor in esophageal adenocarcinoma and colorectal cancer under certain circumstances [43, 44], indicating that an increased level of p62, leading to caspase-2 activation, could improve the prognosis of several tumor types. Here, CASP2 is linked to esophageal adenocarcinoma.